News

The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2029 and key prospects over the forecast period 2019-2029. The global EPA and DHA omega-3 ingredients market is anticipated grow at a CAGR of 7.00% over the forecast period 2019-2029. Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the EPA and DHA omega-3 ingredients market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the EPA and DHA omega-3 ingredients market.

The EPA and DHA omega-3 ingredients market report offers assessment of prevailing opportunities in various regions and evaluates their shares of revenue by the end of different years of the assessment period.

Key regions covered comprise:

• North America (Canada, US)
• Latin America (Argentina, Mexico)
• Europe (NORDIC, UK)
• APEJ (China, India)
• MEA and Japan

After reading the EPA and DHA omega-3 ingredients market report, readers get insight into:

The latest Fact.MR study indicates healthcare facilities, contract research organizations, and educational & research institutes collectively spent ~US$ 1,950 Mn on eCOA, eSource and clinical trials solutions in 2018. The eCOA, eSource & clinical trials market is envisaged to witness substantial traction through 2019, with gains primarily driven by the growing penetration of digitization in healthcare sector and substantial increase in pharma spending on clinical trials.

Rapidly expanding deployment of clinical trial solutions, which contributed to ~40% of the total spending on eCOA, eSource, and clinical trials in 2018, will continue to appeal a widening bandwidth of institutions through 2029, and says the report.

Spending on eCOA Set to Quadruple

The Fact.MR study opines that though the deployment of clinical trial solutions overshadowed the use of Electronic Clinical Outcome Assessment (eCOA), eSource, and EDA in 2018, the market is envisaged to witness a range of changes during the foreseeable period. Growing penetration of Bring Your Own Device (BYOD) trend in clinical trials is highly likely to pace up the use of eCOAs, such as ePROS, ClinROs, ObsROs, and PerfORs across wide range of pharmaceutical companies and research facilities.

The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2029 and key prospects over the forecast period 2019-2029. The global earwax removal aid market is anticipated grow at a CAGR of 4.0% over the forecast period 2019-2029. Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the earwax removal aid market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the earwax removal aid market.

The earwax removal aid market analysis report offers assessment of prevailing opportunities in various regions and evaluates their shares of revenue by the end of different years of the assessment period.

Key regions covered comprise:

• North America (Canada, US)
• Latin America (Argentina, Mexico)
• Europe (NORDIC, UK)
• APEJ (China, India)
• MEA and Japan

After reading the earwax removal aid market report, readers get insight into:

Fact.MR, in its latest research, reveals that ~ 210,890 thousand bottles of cognac were sold in 2018 and the sales are likely to grow by ~5% YOY in 2019. According to the report, cognac is successfully outgrowing the phase of being an occasional drink and is being savored more often, on account of its artful convergence of subtlety and authenticity. This will continue to lift the market revenues to new heights through 2027, with the top five market players commanding for a significant share of it.  This study pinpoints the untapped corners in the global cognac market and finds that the market would grow at a value CAGR of ~ 6.5% during the assessment period.

According to the report, consumer proclivity for premium liquor is estimated to bring in new profits pools for the market players to dive in. Premium alcohol varieties are well-known for their viscosity, texture, and flavor, which gives them an edge over the ordinary liquor grades. Consumers, especially millennials, are increasingly drawn to premium liquor and are more than ready to lose themselves into extravagant experiences. Budding appetite for premium liquor is likely to promise new opportunities for the cognac market players in 2019 and beyond, finds the Fact.MR research study.

Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global canned cocktails market. The canned cocktails market report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth. Each segment along with its sub-segment is analyzed in terms of value and volume. Further, the canned cocktails report elaborates the market behavior of each vendor operating in the canned cocktails market.

The business intelligence study of the canned cocktails market covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). In a bid to recognize the growth prospects in the canned cocktails market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market.

Each segment of the canned cocktails market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:

• North America (Canada, US)
• Latin America (Argentina, Mexico)
• Europe (NORDIC, UK)
• APEJ (China, India)

The key players in the global canned cocktails market report consist of

Fantasiereisen und Meditationen für Kinder

Cover

EINE SPIRITUELLE KRAFTQUELLE - NICHT NUR FÜR KINDER

Fact.MR, in a recent research study, unveils compelling insights into the birch water market during the forecast period. According to the research study, the global birch water market is anticipated to grow at a CAGR of ~ 16%, primarily driven by growing demand for products offering artful convergence of taste and wellness, Birch water holds the status of a well-known health drink in the European countries, while its benefits are being recognized by a large number of North American consumers. This particulars, in turn, validate the lucrativeness of both North American and European markets for market players to pin their focus on.

The birch water market analysis report addresses the below-mentioned queries:
• Why are vendors shifting away from traditional methods of manufacturing keyword?
• How does the global keyword market looks like in the next five years?
• Which end use industry is expected to surpass segment by the end of 2029?
• What innovative products are being introduced by the players in the global keyword market?
• Which regions are showing the fastest market growth?

With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global anticoagulant reversal drugs market as well as the factors responsible for such a growth. Our highly dedicated professionals have inputted critical and accurate insights associated with every industry, and region by doing thorough primary and secondary research.

We leverage space-age industrial and digitization tools to provide avant-garde actionable insights to our clients regarding the anticoagulant reversal drugs market growth. For enhancing readers’ experience, the report starts with a basic overview about the anticoagulant reversal drugs and its classification. Further, we have considered 2016 as the base year, 2026 as the estimated year, 2020-2026 as the stipulated timeframe.

Competitive Assessment

The anticoagulant reversal drugs market report includes global as well as emerging players:
• Portola Pharmaceuticals, Inc.
• Perosphere Pharmaceuticals, Inc.
• Boehringer Ingelheim GmbH
• Amneal Pharmaceuticals, Inc.

Düsseldorf, 17. Januar 2020 Der führende Mehrwertsteuerrückerstatter Global Blue fusioniert mit der an der New York Stock Exchange notierten Far Point Acquisition Corporation. Das Unternehmen notiert dann künftig unter dem Namen Global Blue. "Wir freuen uns auf die Möglichkeiten, die uns ein Börsengang eröffnet. Wir stärken damit unsere Position als global agierendes Unternehmen, das Touristen das beste Reise- und Shoppingerlebnis bietet", sagt Jacques Stern, CEO von Global Blue.

Vorstandsvorsitzender des Unternehmens wird Thomas Farley, CEO von Far Point und ehemaliger Präsident der New York Stock Exchange. Der bisherige Global Blue-Eigentümer Silver Lake and Partners Group bleibt bedeutender Anteilseigner. Als Investor wurde die Alibaba-Tochter Ant Financial Services Group gewonnen, die die weltweit führende Zahlungs- und Lifestyle Plattform Alipay betreibt. Das Unternehmen investiert 125 Millionen US-Dollar und unterstützt die strategische Zusammenarbeit.

The past decade has witnessed substantial developments for the development of targeted therapy for the treatment of cancer, with a number of relevant gene mutations being identified, which has resulted in the finding of drug targets and anticancer drugs, which are propelling changes in terms of data base technologies, which are related to the changes in anticancer drugs. The demand and supply in the worldwide anticancer drugs market is anticipated to rise, thereby supporting the growth in terms of anticancer drugs, with sales being projected to reach a staggering figure of USD 156 billion by the end of the forecast period in 2025.

This growth can be attributed the increased designations of orphan drugs for many of these medications, which provides manufacturers with extra incentives such as tax credits and market exclusivity in terms of clinical trials, and are expected to help support the industry for the foreseeable future.

Governments Push for Awareness Campaigns to Prop Up Anticancer Drugs